Please login to the form below

Not currently logged in
Email:
Password:

Rare Diseases and Orphan Drugs


Rare Diseases and Orphan Drugs

This category relates to the marketing of an orphan drug (for rare diseases or disorders), at any phase of the product life cycle. Entrants will need to demonstrate a thorough understanding of the specific environment and show appropriate marketing approach to drive the business forward.

Work conducted during the 18-month period between July 2010 and December 2011 will be eligible.


Judging criteria:

  • Recognition of the specific health environment
  • Evidence that the drug eas built upon customer insight
  • Explanation of positioning and evidence of effective brand building
  • Market access strategy & execution
  • Effective integration of tailored marketing tools and activities
  • Evidence of changed behaviours and enhanced health outcomes



Sponsors

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics